BDMD

Baird Medical Investment Holdings Limited

Investor Moves

Name	Value	Action	Change	Price	Current Price
Ken GriffinCitadel Advisors $-153.2K ExitQ1 2026 $153k -- $1.58
Ken GriffinCitadel Advisors $153k112.7k shares ExitQ4 2025 $99k $1.36 $1.58
Ken GriffinCitadel Advisors $153k112.7k shares AddQ4 2025 $55k $1.36 $1.58

News

prnewswire.comBaird Medical Establishes Global Headquarters in New York City, Reinforcing Commitment to U.S. Commercial Expansionprnewswire.comJun 9

prnewswire.comBaird Medical Reports Full Year 2025 Financial Results and Provides Corporate Updateprnewswire.comApr 29

Trade BDMD

About Baird Medical Investment Holdings Limited

Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.

CEO: Haimei Wu
IPO Date: Dec 16, 2021

Market Data

Open: $1.22
High: $1.22
Low: $1.11
Volume: 49.8K
Avg Volume: 277K
52W High: $7.26
52W Low: $0.757

Valuation

Market Cap: $45M
Enterprise Value: $65M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-1.4M
Revenue: $23M
Net Income: $-27M
Cash: $178k
Debt: $19M

Events

IPODec 16

NASDAQ